| Dr Gregory F Kellermeyer, MD | |
|
7701 Sheridan Blvd, Westminster, CO 80003-2605 | |
| (303) 338-4545 | |
| Not Available |
| Full Name | Dr Gregory F Kellermeyer |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 23 Years |
| Location | 7701 Sheridan Blvd, Westminster, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043385396 | NPI | - | NPPES |
| 97154024 | Medicaid | CO | |
| 023459 | Other | CO | KAISER COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | A97506 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 41564 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Permanente Medical Group Pc | 1254238454 | 1113 |
News Archive
Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any additional benefit over shorter courses.
Quantros announces the availability of MMSEA Manager, an application facilitating the online reporting of claims data required by CMS for Medicare clients who are part of a lawsuit and/or an ongoing medical payment or settlement. Testing and optional submission of MMSEA claim input files began January 1, 2010, with mandatory submission beginning April 1, 2010. The application is the latest addition to the Quantros Safety and Risk Management (SRM) product family.
GE Hitachi Nuclear Energy (GEH) announced today it has been selected by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help develop a U.S. supply of a radioisotope used in more than 20 million diagnostic medical procedures in the United States each year.
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease.
New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.
› Verified 2 days ago
| Entity Name | Colorado Permanente Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760599724 PECOS PAC ID: 1254238454 Enrollment ID: O20031216000640 |
News Archive
Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any additional benefit over shorter courses.
Quantros announces the availability of MMSEA Manager, an application facilitating the online reporting of claims data required by CMS for Medicare clients who are part of a lawsuit and/or an ongoing medical payment or settlement. Testing and optional submission of MMSEA claim input files began January 1, 2010, with mandatory submission beginning April 1, 2010. The application is the latest addition to the Quantros Safety and Risk Management (SRM) product family.
GE Hitachi Nuclear Energy (GEH) announced today it has been selected by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help develop a U.S. supply of a radioisotope used in more than 20 million diagnostic medical procedures in the United States each year.
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease.
New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory F Kellermeyer, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-3382 | Dr Gregory F Kellermeyer, MD 7701 Sheridan Blvd, Westminster, CO 80003-2605 Ph: (303) 338-4545 |
News Archive
Patients with cystic fibrosis recover from exacerbations equally well if they are treated at home or in a hospital, according to researchers from Johns Hopkins University. Furthermore, longer treatment with antibiotics does not appear to offer any additional benefit over shorter courses.
Quantros announces the availability of MMSEA Manager, an application facilitating the online reporting of claims data required by CMS for Medicare clients who are part of a lawsuit and/or an ongoing medical payment or settlement. Testing and optional submission of MMSEA claim input files began January 1, 2010, with mandatory submission beginning April 1, 2010. The application is the latest addition to the Quantros Safety and Risk Management (SRM) product family.
GE Hitachi Nuclear Energy (GEH) announced today it has been selected by the U.S. Department of Energy's National Nuclear Security Administration (NNSA) to help develop a U.S. supply of a radioisotope used in more than 20 million diagnostic medical procedures in the United States each year.
Bruker today unveils two new preclinical imaging systems at the World Molecular Imaging Congress 2016 in New York. The new systems are designed to deliver highest performance and improved convenience for routine imaging, and enable novel translational research into the causes, progression, as well as potential diagnosis and treatment of disease.
New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors.
› Verified 2 days ago
Dr. Nancy Karrel Griffin Stebbins, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Dr. Todd W Stull, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12365 Huron St Ste 1600, Westminster, CO 80234 Phone: 970-528-5030 | |
Ernest Edward Nitka, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-952-4060 Fax: 303-925-4061 | |
Dr. Glenn Tetsuo Kimata, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8771 Wolff Ct, Suite 115, Westminster, CO 80031 Phone: 303-650-8005 Fax: 303-412-5891 | |
Dr. Andreea I Arvinte, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7701 Sheridan Blvd, Westminster, CO 80003 Phone: 303-338-4545 | |
Kimberly A Horiuchi, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14300 Orchard Pkwy, Westminster, CO 80023 Phone: 303-925-4060 Fax: 303-925-4061 |